Inhaled drug shows promise for stopping lung bleeding in kids

NCT ID NCT07481682

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether giving tranexamic acid (a clot-promoting drug) as an inhaled mist helps stop lung bleeding faster in children in the intensive care unit. 100 children with lung bleeding were split into two groups: one got the inhaled drug plus standard care, the other got standard care alone. The inhaled group stopped bleeding sooner and had fewer side effects, suggesting this could be a safer way to manage this emergency.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tranexamic acid
What this could lead to
If this approach is confirmed, it could offer a safer and more effective way to control lung bleeding in critically ill children, potentially reducing hospital stays and deaths.
What could go wrong
This is a single-center study with 100 children, so results may not apply to all patients. The treatment is not yet standard, and more research is needed to confirm safety and effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTENSIVE CARE UNIT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tanta University

    Tanta, El-Gharbia, 31527, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.